Dashboard
Faculty
Programme
Login
Dashboard
Faculty
Programme
Login
From the Patient's perspective: Successes and challenges related to Beta Cell Replacement therapies past, present and future
Thursday October 21, 2021 from 08:00 to 08:45
Room: General Session
201.1 Perspective from pancreas transplant patient
Log in to add to favorites
Add Personal Notes
Karin Hehenberger, United States
Founder and CEO
Lyfebulb
Overview
Presentations by Karin Hehenberger
Thu-21 from 08:00 - 08:45 in room General Session
From the Patient's perspective: Successes and challenges related to Beta Cell Replacement therapies past, present and future
Perspective from pancreas transplant patient
Email:
info@ipita2021.org
514-874-1717 x203
© 2025 Virtual IPITA 2021